Showing results (51-60 of 426) with videos related to
Sort By:
Pageof 43
Toxicology|November 1, 1990
Excretion and blood radioactivity levels following [14C]senecionine administration in the ratJ E Estep, M W Lamé, H J SegallToxicology|March 30, 1993
Strain differences in the response of Fischer 344 and Sprague-Dawley rats to monocrotaline induced pulmonary vascular diseaseL C Pan, D W Wilson, H J SegallThe Journal of Biological Chemistry|December 25, 1980
Multiple factors required for accurate initiation of transcription by purified RNA polymerase IIT Matsui, J Segall, P A Weil, et al.Vascular Pharmacology|November 8, 2005
The BMP type II receptor is located in lipid rafts, including caveolae, of pulmonary endothelium in vivo and in vitroM Ramos, M W Lamé, H J Segall, et al.Cell|October 1, 1979
Selective and accurate initiation of transcription at the Ad2 major late promotor in a soluble system dependent on purified RNA polymerase II and DNAP A Weil, D S Luse, J Segall, et al.Vascular Pharmacology|March 6, 2007
Monocrotaline pyrrole induces Smad nuclear accumulation and altered signaling expression in human pulmonary arterial endothelial cellsM Ramos, M W Lamé, H J Segall, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1991
Metabolism of [14C]monocrotaline by isolated perfused rat liverM W Lamé, A D Jones, D Morin, et al.Archives of Biochemistry and Biophysics|April 1, 1992
Quantification of cytochrome P450 reductase gene expression in human tissuesE A Shephard, C N Palmer, H J Segall, et al.Toxicology and Applied Pharmacology|November 1, 1996
Cell cycle alterations associated with covalent binding of monocrotaline pyrrole to pulmonary artery endothelial cell DNAH C Thomas, M W Lamé, D W Wilson, et al.Toxicology and Applied Pharmacology|July 18, 2000
DNA damage cell checkpoint activities are altered in monocrotaline pyrrole-induced cell cycle arrest in human pulmonary artery endothelial cellsD W Wilson, M W Lamé, S K Dunston, et al.Pageof 43